We are live on ! Find out more
CM

Castleark Management Portfolio holdings

AUM $3.02B
1-Year Est. Return 53.92%
This Fund
S&P 500
This Quarter Est. Return
+13.14%
1 Year Est. Return
+53.92%
3 Year Est. Return
+208.37%
5 Year Est. Return
+342.22%
10 Year Est. Return
+3,246.09%
AUM
$3.55B
AUM Growth
+$532M
Cap. Flow
+$232M
Cap. Flow %
6.53%
Top 10 Hldgs %
22.4%
Holding
485
New
170
Increased
65
Reduced
91
Closed
143

Top Sells

Rank Stock Value
1
TJX icon
TJX Companies
TJX
+$86.7M
2
PH icon
Parker-Hannifin
PH
+$84.7M
3
C icon
Citigroup
C
+$83.7M
4
CPRI icon
Capri Holdings
CPRI
+$83.4M
5
COST icon
Costco
COST
+$73.4M

Sector Composition

Rank Sector Weight
1 Technology 19.6%
2 Energy 14.69%
3 Healthcare 14.39%
4 Consumer Discretionary 13.85%
5 Industrials 11.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLD icon
101
SPDR Gold Trust
GLD
$131B
$9.12M 0.26%
+78,500
New +$10.1M
LOGM
102
DELISTED
LogMein, Inc.
LOGM
$9.09M 0.26%
+197,331
New +$5.83M
HEES
103
DELISTED
H&E Equipment Services
HEES
$8.96M 0.25%
+222,338
New +$5.29M
HA
104
DELISTED
Hawaiian Holdings, Inc.
HA
$8.92M 0.25%
+662,919
New +$4.74M
BEE
105
DELISTED
STRATEGIC HOTELS & RESORTS, INC
BEE
$8.77M 0.25%
+752,625
New +$6.56M
STE icon
106
Steris
STE
$22.8B
$8.76M 0.25%
+162,415
New +$7.06M
DOC
107
DELISTED
PHYSICIANS REALTY TRUST
DOC
$8.73M 0.25%
+636,089
New +$7.43M
PBI icon
108
Pitney Bowes
PBI
$2.41B
$8.71M 0.25%
+348,595
New +$5.72M
RMBS icon
109
Rambus
RMBS
$9.09B
$8.67M 0.24%
+694,887
New +$6.36M
CRZO
110
DELISTED
Carrizo Oil & Gas Inc
CRZO
$8.46M 0.24%
157,228
+144,128
+1,100% +$4.79M
PVA
111
DELISTED
PENN VIRGINIA CORP
PVA
$8.44M 0.24%
+664,087
New +$3.46M
IPHS
112
DELISTED
Innophos Holdings, Inc.
IPHS
$8.38M 0.24%
+152,109
New +$7.67M
WMB icon
113
Williams Companies
WMB
$85.7B
$8.34M 0.24%
+150,600
New +$5.28M
UEIC icon
114
Universal Electronics
UEIC
$58.6M
$8.33M 0.23%
+168,725
New +$5.31M
JBLU icon
115
JetBlue
JBLU
$2.2B
$8.09M 0.23%
+761,404
New +$4.92M
OSPN icon
116
OneSpan
OSPN
$586M
$8.01M 0.23%
+426,500
New +$3.52M
PCRX icon
117
Pacira BioSciences
PCRX
$1.03B
$7.83M 0.22%
80,836
-47,999
-37% -$1.75M
RUSHA icon
118
Rush Enterprises Class A
RUSHA
$6.36B
$7.81M 0.22%
+525,515
New +$6.03M
MTOR
119
DELISTED
MERITOR, Inc.
MTOR
$7.78M 0.22%
+717,198
New +$5.55M
TXRH icon
120
Texas Roadhouse
TXRH
$13.7B
$7.49M 0.21%
+269,125
New +$6.77M
ARUN
121
DELISTED
ARUBA NETWORKS, INC.
ARUN
$7.48M 0.21%
+346,475
New +$6.05M
ETP
122
DELISTED
Energy Transfer Partners L.p.
ETP
$7.35M 0.21%
114,890
+32,810
+40% +$1.69M
ZD icon
123
Ziff Davis
ZD
$2B
$7.35M 0.21%
+171,184
New +$7.17M
QLYS icon
124
Qualys
QLYS
$4.75B
$7.26M 0.2%
+272,950
New +$5.12M
CLW icon
125
Clearwater Paper
CLW
$351M
$7.21M 0.2%
+119,959
New +$5.82M

Similar funds

Castleark Management's Q3 2013 Portfolio in Review

As of Q3 2013, Castleark Management held 485 positions worth $3.55B, up 18% from $3.01B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Castleark Management deployed $232M of net new capital in Q3 2013, opening 170 new positions and adding to 65 existing holdings. Its largest new stake was Celgene Corp: 1,610,214 shares worth $76.3M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 10% a quarter earlier, followed by Energy and Healthcare.

On the sell side, the largest reduction was TJX Companies, an estimated $86.7M trimmed.

  • Castleark Management's largest Q3 2013 buy was Celgene Corp: 1,610,214 shares worth $76.3M.
  • Castleark Management added most to Apple in Q3 2013, an estimated $426M increase.
  • Castleark Management's biggest Q3 2013 reduction was TJX Companies, cutting an estimated $86.7M.
  • Castleark Management fully exited UnitedHealth in Q3 2013, selling an estimated $70.5M.
  • Castleark Management's ten largest holdings make up 22% of its $3.55B portfolio in Q3 2013.
  • Castleark Management opened 170 new positions and closed 143 in Q3 2013.
  • Castleark Management's portfolio value rose 18% quarter-over-quarter to $3.55B.

Based on Castleark Management's 13F filing for Q3 2013, filed 20 Nov 2013.